Documentation and Access. Upon request by ChemGenics from time to time, PerSeptive shall, within a reasonable time thereafter, deliver to ChemGenics copies of reasonable then-existing documentation describing the Licensed Technology which is reasonably related to the scope of ChemGenics's activities within the Field. PerSeptive shall give access to and use reasonable efforts to keep ChemGenics apprised of all ongoing and future Licensed Technology created by PerSeptive and its Affiliates which is or may be useful in the Field, and shall reasonably cooperate with and provide advice to ChemGenics with respect to the implementation of new Technology which is Licensed Technology in the Field subject to the terms of this Agreement, it being understood that the level of effort required by this Section is less than the level of effort required by the Consulting and Interim Services Agreement (as defined in the Master Agreement). PerSeptive further agrees, at the request of ChemGenics, to provide reasonable additional consulting services to ChemGenics in return for commercially reasonable compensation. PerSeptive shall at all times during the term of this Agreement provide ChemGenics with access to PerSeptive's patent applications and notify ChemGenics when any patents issue thereon subject to Sections 9.2, 9.3 and 9.4 hereof. In the event the ChemGenics shall have reason to believe that PerSeptive has not complied with the requirements of this Section 5.1, it shall so notify PerSeptive and PerSeptive shall be given a reasonable opportunity to cure such non-compliance.
Appears in 2 contracts
Sources: License Agreement (Millennium Pharmaceuticals Inc), License Agreement (Chemgenics Pharmaceuticals Inc)